<DOC>
	<DOCNO>NCT01434108</DOCNO>
	<brief_summary>The main objective evaluate effectiveness experimental drug reduce plasma ammonia concentration dose safe well tolerate . Ammonia usually rise significantly hour gastrointestinal bleeding patient cirrhosis liver . This increase concentration ammonia facilitates development hepatic encephalopathy . The study divide two part : Part A : Open-label , dose-escalating , single cohort study . The goal phase confirm tolerance safety dose OP propose study accord result phase I phase II study healthy subject stable outpatient cirrhosis . Part B : Multi-center ( 2 University Hospitals ) , double-blind , randomize , parallel-group trial . Assignment treatment do accord list ( one study site ) random number block conceal end study . The control group assign placebo 1:1 ratio . The placebo treatment mask .</brief_summary>
	<brief_title>Effects Administration Ornithine Phenylacetate Patients With Cirrhosis Upper Gastrointestinal Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Phenylacetic acid</mesh_term>
	<criteria>Inclusion criterion Cirrhosis liver ; diagnose clinical , laboratory radiological finding . Upper gastrointestinal bleeding , judge clinical sign ( hematemesis , melena , anemia ) combine endoscopic data . Bleeding active within 24 hour prior inclusion ; sign activity define presence blood gastrointestinal tract symptom attributable bleeding ( hypotension , tachycardia , etc. ) . Age 18 75 year . Informed consent patient . In case inability provide inform consent due impair mental status secondary hepatic encephalopathy inform consent provide next kin confirm patient he/she recovers hepatic encephalopathy . Absence exclusion criterion . Exclusion criterion Terminal illness ( e.g . advanced hepatocellular carcinoma ) . Need mechanical ventilation . Renal impairment , define creatinine &gt; 1.5 mg/dl need hemodialysis . Pregnant breastfeeding . Premenopausal woman capable bear child follow reliable method birth control negative result pregnancy test prior inclusion . Known suspected hypersensitivity allergic reaction ornithine phenylacetate . Use medication know interfere clearance either ornithine and/or phenylacetate , antibiotic penicillin group probenicid . Use medication may induce hyperammonemia ; haloperidol , valproic acid , systemic corticosteroid . History known infection human immunodeficiency virus ( HIV ) . Neurological comorbidities impair mental status allow adequately assess presence outcome hepatic encephalopathy . The presence electrocardiogram QTcF &gt; 500 msec</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>cirrhosis , gastrointestinal bleeding</keyword>
</DOC>